Tjønnfjord GE, Osnes LTN, Spetalen S, Haave U, Popperud TH, Maniaol AH, Østlie I, Bajelan L, Hamnvik LHD, Marvyin K, Miskovic D, Tjønnfjord EB, Winje K, Moksnes M, Tvedt THA, Kvam AK, Malecka A(2026) Anti-MAG Polyneuropathy: Characterization of the Monoclonal Gammopathy and Clonal B-Cell Population J Immunol Res, 2026(1), e1959235 DOI 10.1155/jimr/1959235, PubMed 42396941
Publications 2025
Gilhus NE, Maniaol AH(2025) Myasthenia gravis - new, improved treatment Tidsskr Nor Laegeforen, 145(15) DOI 10.4045/tidsskr.25.0582, PubMed 41410951
Publications 2024
Howard JF, Bresch S, Farmakidis C, Freimer M, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Nowak RJ, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Bloemers J, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Vanderkelen M, Leite MI, RAISE-XT Study Team*(2024) Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study Ther Adv Neurol Disord, 17, 17562864241243186 DOI 10.1177/17562864241243186, PubMed 38638673
Novy C, Busk ØL, Tysnes OB, Landa SS, Aanjesen TN, Alstadhaug KB, Bjerknes TL, Bjørnå IK, Bråthen G, Dahl E, Demic N, Fahlström M, Flemmen HØ, Hallerstig E, HogenEsch I, Kampman MT, Kleveland G, Kvernmo HB, Ljøstad U, Maniaol A, Morsund AH, Nakken O, Olsen CG, Schlüter K, Utvik MS, Yaseen R, Holla ØL, Holmøy T, Høyer H(2024) Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis Brain Commun, 6(2), fcae087 DOI 10.1093/braincomms/fcae087, PubMed 38585669
Olsen CG, Malmberg VN, Fahlström M, Alstadhaug KB, Bjørnå IK, Braathen GJ, Bråthen G, Demic N, Hallerstig E, Hogenesch I, Horn MA, Kampman MT, Kleveland G, Ljøstad U, Maniaol A, Morsund ÅH, Nakken O, Schlüter K, Schuler S, Seim E, Flemmen HØ, Tysnes OB, Holmøy T, Høyer H(2024) Amyotrophic lateral sclerosis caused by the C9orf72 expansion in Norway - prevalence, ancestry, clinical characteristics and sociodemographic status Amyotroph Lateral Scler Frontotemporal Degener, 26(1-2), 132-140 DOI 10.1080/21678421.2024.2405118, PubMed 39316038
Weiss MD, Freimer M, Leite MI, Maniaol A, Utsugisawa K, Bloemers J, Boroojerdi B, Howard E, Savic N, Howard JF(2024) Improvement of fatigue in generalised myasthenia gravis with zilucoplan J Neurol, 271(5), 2758-2767 DOI 10.1007/s00415-024-12209-3, PubMed 38400914
Publications 2023
Howard JF, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI, RAISE Study Team(2023) Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study Lancet Neurol, 22(5), 395-406 DOI 10.1016/S1474-4422(23)00080-7, PubMed 37059508
Publications 2022
Olsen CG, Busk ØL, Aanjesen TN, Alstadhaug KB, Bjørnå IK, Braathen GJ, Breivik KL, Demic N, Flemmen HØ, Hallerstig E, HogenEsch I, Holla ØL, Jøntvedt AB, Kampman MT, Kleveland G, Kvernmo HB, Ljøstad U, Maniaol A, Morsund ÅH, Nakken O, Novy C, Rekand T, Schlüter K, Schüler S, Tveten K, Tysnes OB, Holmøy T, Høyer H(2022) Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study Neuroepidemiology, 56(4), 271-282 DOI 10.1159/000525091, PubMed 35576897
Publications 2021
Creary LE, Gangavarapu S, Caillier SJ, Cavalcante P, Frangiamore R, Lie BA, Bengtsson M, Harbo HF, Brauner S, Hollenbach JA, Oksenberg JR, Bernasconi P, Maniaol AH, Hammarström L, Mantegazza R, Fernández-Viña MA(2021) Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations Front Immunol, 12, 667336 DOI 10.3389/fimmu.2021.667336, PubMed 34163474
Publications 2018
Vincent A, Huda S, Cao M, Cetin H, Koneczny I, Rodriguez Cruz PM, Jacobson L, Viegas S, Jacob S, Woodhall M, Nagaishi A, Maniaol A, Damato V, Leite MI, Cossins J, Webster R, Palace J, Beeson D(2018) Serological and experimental studies in different forms of myasthenia gravis Ann N Y Acad Sci, 1413(1), 143-153 DOI 10.1111/nyas.13592, PubMed 29377162
Publications 2017
Boldingh MI, Maniaol A, Brunborg C, Dekker L, Lipka A, Niks EH, Verschuuren J, Tallaksen C(2017) Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe Muscle Nerve, 55(6), 819-827 DOI 10.1002/mus.25408, PubMed 27641227
Huda S, Waters P, Woodhall M, Leite MI, Jacobson L, De Rosa A, Maestri M, Ricciardi R, Heckmann JM, Maniaol A, Evoli A, Cossins J, Hilton-Jones D, Vincent A(2017) IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG Neurol Neuroimmunol Neuroinflamm, 4(4), e357 DOI 10.1212/NXI.0000000000000357, PubMed 28626780
Publications 2016
Boldingh MI, Maniaol AH, Brunborg C, Weedon-Fekjær H, Verschuuren JJ, Tallaksen CM(2016) Increased risk for clinical onset of myasthenia gravis during the postpartum period Neurology, 87(20), 2139-2145 DOI 10.1212/WNL.0000000000003339, PubMed 27770065
Popperud TH, Boldingh MI, Brunborg C, Faiz KW, Heldal AT, Maniaol AH, Müller KI, Rasmussen M, Øymar K, Kerty E(2016) Juvenile myasthenia gravis in Norway: A nationwide epidemiological study Eur J Paediatr Neurol, 21(2), 312-317 DOI 10.1016/j.ejpn.2016.09.001, PubMed 27666466
Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol Aet al.(2016) Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen J Neuroimmunol, 292, 108-15 DOI 10.1016/j.jneuroim.2016.01.018, PubMed 26943968
Publications 2015
Boldingh MI, Dekker L, Maniaol AH, Brunborg C, Lipka AF, Niks EH, Verschuuren JJ, Tallaksen CM(2015) An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts Health Qual Life Outcomes, 13, 115 DOI 10.1186/s12955-015-0298-1, PubMed 26232146
Boldingh MI, Maniaol AH, Brunborg C, Dekker L, Heldal AT, Lipka AF, Popperud TH, Niks EH, Verschuuren JJ, Tallaksen CM(2015) Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries Neuroepidemiology, 44(4), 221-31 DOI 10.1159/000431036, PubMed 26068011
Seldin MF, Alkhairy OK, Lee AT, Lamb JA, Sussman J, Pirskanen-Matell R, Piehl F, Verschuuren JJGM, Kostera-Pruszczyk A, Szczudlik P, McKee D, Maniaol AH, Harbo HF, Lie BA, Melms A, Garchon HJ, Willcox N, Gregersen PK, Hammarstrom L(2015) Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations Mol Med, 21(1), 769-781 DOI 10.2119/molmed.2015.00232, PubMed 26562150
Tsonis AI, Zisimopoulou P, Lazaridis K, Tzartos J, Matsigkou E, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric Set al.(2015) MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study J Neuroimmunol, 284, 10-7 DOI 10.1016/j.jneuroim.2015.04.015, PubMed 26025053
Publications 2014
Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C, Mantegazza R, Berrih-Aknin S, Miller A(2014) VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis Ann Clin Transl Neurol, 1(5), 329-39 DOI 10.1002/acn3.51, PubMed 25356403
Publications 2013
Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen Cet al.(2013) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis J Autoimmun, 52, 139-45 DOI 10.1016/j.jaut.2013.12.004, PubMed 24373505
Publications 2012
Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, Simpfendorfer KR, Pirskanen-Matell R, Piehl F, Pan-Hammarstrom Q, Verschuuren JJ, Titulaer MJ, Niks EH, Marx A, Ströbel P, Tackenberg B, Pütz M, Maniaol A, Elsais A, Tallaksen C, Harbo HF, Lie BA, Raychaudhuri S, de Bakker PI, Melms A, Garchon HJ, Willcox N, Hammarstrom L, Seldin MF(2012) Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08 Ann Neurol, 72(6), 927-35 DOI 10.1002/ana.23691, PubMed 23055271
Maniaol AH, Boldingh M, Brunborg C, Harbo HF, Tallaksen CME(2012) Smoking and socio-economic status may affect myasthenia gravis Eur J Neurol, 20(3), 453-460 DOI 10.1111/j.1468-1331.2012.03843.x, PubMed 22934661
Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF(2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population PLoS One, 7(5), e36603 DOI 10.1371/journal.pone.0036603, PubMed 22590574
Publications 2011
Alseth EH, Maniaol AH, Elsais A, Nakkestad HL, Tallaksen C, Gilhus NE, Skeie GO(2011) Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients Muscle Nerve, 43(4), 574-7 DOI 10.1002/mus.21919, PubMed 21305573
Publications 2010
Maniaol AH, Brunborg C, Tallaksen CM(2010) Development and validation of a self-administered questionnaire for myasthenia gravis patients Neuroepidemiology, 34(4), 253-61 DOI 10.1159/000297753, PubMed 20299807
